Published in Stem Cells Transl Med on February 26, 2015
Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease. J Gastroenterol (2015) 0.93
Evaluating the effectiveness of transferrin receptor-1 (TfR1) as a magnetic resonance reporter gene. Contrast Media Mol Imaging (2016) 0.77
Emergence of clonal chromosomal alterations during the mesenchymal stromal cell cultivation. Mol Cytogenet (2015) 0.77
Articular cartilage tissue engineering: the role of signaling molecules. Cell Mol Life Sci (2016) 0.75
Evaluation of Three Devices for the Isolation of the Stromal Vascular Fraction from Adipose Tissue and for ASC Culture: A Comparative Study. Stem Cells Int (2017) 0.75
A strategy to ensure safety of stem cell-derived retinal pigment epithelium cells. Stem Cell Res Ther (2016) 0.75
Autologous Cells for Kidney Bioengineering. Curr Transplant Rep (2016) 0.75
MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis. Stem Cell Reports (2017) 0.75
Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls. Therap Adv Gastroenterol (2016) 0.75
Imaging technologies for monitoring the safety, efficacy and mechanisms of action of cell-based regenerative medicine therapies in models of kidney disease. Eur J Pharmacol (2016) 0.75
Human stem cells alter the invasive properties of somatic cells via paracrine activation of mTORC1. Nat Commun (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (2008) 12.59
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet (2004) 11.77
Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell (2009) 10.52
Hematopoietic stem-cell transplantation. N Engl J Med (2006) 10.45
Photoacoustic tomography: in vivo imaging from organelles to organs. Science (2012) 9.99
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol (2003) 9.15
Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70
Immunogenicity of induced pluripotent stem cells. Nature (2011) 7.31
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol (2002) 6.92
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A (2002) 6.05
Human embryonic stem cells derived by somatic cell nuclear transfer. Cell (2013) 5.91
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci (2009) 5.58
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med (2009) 5.50
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol (2003) 5.35
Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med (2005) 5.24
CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell (2009) 5.22
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation (2003) 5.07
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science (2013) 4.94
An overview of tissue and whole organ decellularization processes. Biomaterials (2011) 4.78
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol (2003) 4.62
Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater (2008) 4.36
Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature (2013) 4.19
Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell (2011) 4.02
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol (2003) 3.74
Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet (2005) 3.73
Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med (1984) 3.70
Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol (2012) 3.50
The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer (2011) 3.42
Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report. J Neurosurg Spine (2014) 3.38
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation (2005) 3.33
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol (2011) 3.05
High sensitivity of in vivo detection of gold nanorods using a laser optoacoustic imaging system. Nano Lett (2007) 3.01
Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am (2006) 2.95
A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev (2012) 2.76
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell (2011) 2.71
Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater (2003) 2.66
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J (2007) 2.63
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Methods for making induced pluripotent stem cells: reprogramming à la carte. Nat Rev Genet (2011) 2.60
Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat (2002) 2.52
Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell (2013) 2.45
Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle (2009) 2.30
A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One (2012) 2.24
Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci (2003) 2.22
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med (2013) 2.10
Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging. Cell Transplant (2014) 2.09
Organ engineering based on decellularized matrix scaffolds. Trends Mol Med (2011) 2.07
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell (2013) 2.02
FDA regulation of stem-cell-based therapies. N Engl J Med (2006) 2.01
Human somatic cell nuclear transfer using adult cells. Cell Stem Cell (2014) 1.98
Tracking neural stem cells in patients with brain trauma. N Engl J Med (2006) 1.95
Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation. Cell Stem Cell (2011) 1.91
Embryonic stem cell pioneer Geron exits field, cuts losses. Nat Biotechnol (2012) 1.88
Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells (2007) 1.84
Quantum dot imaging for embryonic stem cells. BMC Biotechnol (2007) 1.78
Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans (2005) 1.78
Long-distance migration and colonization of transplanted neural stem cells. Cell (2014) 1.77
Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell (2012) 1.75
Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.73
Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med (2006) 1.72
Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol (2005) 1.69
2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl (2010) 1.66
Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol (2009) 1.65
Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One (2009) 1.64
Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res (2010) 1.62
HLA-haplotype banking and iPS cells. Nat Biotechnol (2008) 1.61
Assessing the safety of stem cell therapeutics. Cell Stem Cell (2011) 1.60
Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed (2010) 1.60
Noninvasive bioluminescence imaging in small animals. ILAR J (2008) 1.59
PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. Nat Protoc (2006) 1.57
111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med (2004) 1.53
Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair (2006) 1.53
Humanized mice: are we there yet? J Exp Med (2005) 1.49
Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate. Stem Cell Reports (2013) 1.48
Photoacoustic tomography: fundamentals, advances and prospects. Contrast Media Mol Imaging (2011) 1.46
Lessons from human teratomas to guide development of safe stem cell therapies. Nat Biotechnol (2012) 1.43
Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab (2009) 1.43
Anoikis: roadblock to cell transplantation? Cell Transplant (2002) 1.38
Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk's expression. J Nucl Med (2006) 1.38
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. Circ Cardiovasc Imaging (2008) 1.34
Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair. Cell Mol Neurobiol (2006) 1.30
Photoacoustic tomography of joints aided by an Etanercept-conjugated gold nanoparticle contrast agent-an ex vivo preliminary rat study. Nanotechnology (2008) 1.29
Stem cell transplantation (cord blood transplants). Hematology Am Soc Hematol Educ Program (2004) 1.28
Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Physiol Genomics (2006) 1.26
In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed (2013) 1.25
Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PLoS One (2012) 1.24
Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- and diffusion-MRI. Biomaterials (2012) 1.22
In vivo bioluminescence for tracking cell fate and function. Am J Physiol Heart Circ Physiol (2011) 1.20
Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. Theranostics (2012) 1.19